Demetrius Matassov

1.9k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Demetrius Matassov is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Demetrius Matassov has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Demetrius Matassov's work include Viral Infections and Outbreaks Research (11 papers), Viral Infections and Vectors (8 papers) and Hepatitis B Virus Studies (5 papers). Demetrius Matassov is often cited by papers focused on Viral Infections and Outbreaks Research (11 papers), Viral Infections and Vectors (8 papers) and Hepatitis B Virus Studies (5 papers). Demetrius Matassov collaborates with scholars based in United States, France and Nigeria. Demetrius Matassov's co-authors include Adolfo Garcı́a-Sastre, David T. Levy, Sabine Brandt, Peter Palese, Andrej Egorov, Thomas Muster, Joan E. Durbin, Zahra Zakeri, Marianna Sikorska and Julie Leblanc and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Virology.

In The Last Decade

Demetrius Matassov

17 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1998 825 citations Adolfo Garcı́a-Sastre, Andrej Egorov et al. Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Demetrius Matassov United States	14	855	616	555	347	116	17	1.5k
Henju Marjuki United States	19	1.3k 1.5×	590 1.0×	498 0.9×	432 1.2×	246 2.1×	43	1.7k
Olivia Perwitasari United States	14	820 1.0×	1.1k 1.8×	612 1.1×	554 1.6×	104 0.9×	15	1.9k
Jeremy C. Jones United States	20	947 1.1×	339 0.6×	352 0.6×	318 0.9×	231 2.0×	53	1.3k
Wenjun Song China	23	1.0k 1.2×	379 0.6×	706 1.3×	550 1.6×	332 2.9×	52	1.9k
Christy S. Barrios United States	15	407 0.5×	617 1.0×	237 0.4×	412 1.2×	85 0.7×	27	1.4k
Min‐Hui Wong United States	19	795 0.9×	362 0.6×	638 1.1×	270 0.8×	45 0.4×	41	1.5k
Fumitaka Momose Japan	15	656 0.8×	347 0.6×	272 0.5×	598 1.7×	48 0.4×	29	1.1k
Bing Huang China	18	599 0.7×	198 0.3×	257 0.5×	293 0.8×	116 1.0×	48	1.0k
Matloob Husain New Zealand	20	634 0.7×	408 0.7×	144 0.3×	496 1.4×	59 0.5×	43	1.2k
Sebla B. Kutluay United States	21	394 0.5×	522 0.8×	504 0.9×	860 2.5×	24 0.2×	31	1.7k

Countries citing papers authored by Demetrius Matassov

Since Specialization

Citations

This map shows the geographic impact of Demetrius Matassov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demetrius Matassov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demetrius Matassov more than expected).

Fields of papers citing papers by Demetrius Matassov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demetrius Matassov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demetrius Matassov. The network helps show where Demetrius Matassov may publish in the future.

Co-authorship network of co-authors of Demetrius Matassov

This figure shows the co-authorship network connecting the top 25 collaborators of Demetrius Matassov. A scholar is included among the top collaborators of Demetrius Matassov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demetrius Matassov. Demetrius Matassov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Matassov, Demetrius, Lisa Evans DeWald, Stefan Hamm, et al.. (2024). Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines. 12(8). 858–858. 3 indexed citations

Woolsey, Courtney, Viktoriya Borisevich, Krystle N. Agans, et al.. (2023). A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus. The Journal of Infectious Diseases. 228(Supplement_7). S660–S670. 10 indexed citations

Woolsey, Courtney, Robert W. Cross, Krystle N. Agans, et al.. (2022). A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. PLoS neglected tropical diseases. 16(5). e0010433–e0010433. 31 indexed citations

Eldridge, John H., Michael A. Egan, Demetrius Matassov, et al.. (2021). A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses. Vaccine. 39(38). 5436–5441. 4 indexed citations

Clarke, David K., Rong Xu, Demetrius Matassov, et al.. (2020). Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. The Lancet Infectious Diseases. 20(4). 455–466. 23 indexed citations

Woolsey, Courtney, Allen Jankeel, Demetrius Matassov, et al.. (2020). Immune correlates of postexposure vaccine protection against Marburg virus. Scientific Reports. 10(1). 3071–3071. 20 indexed citations

Cross, Robert W., Rong Xu, Demetrius Matassov, et al.. (2019). Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. Journal of Clinical Investigation. 130(1). 539–551. 54 indexed citations

Woolsey, Courtney, Joan B. Geisbert, Demetrius Matassov, et al.. (2018). Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates. The Journal of Infectious Diseases. 218(suppl_5). S582–S587. 20 indexed citations

Matassov, Demetrius, Chad E. Mire, Theresa Latham, et al.. (2017). Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge. Journal of Virology. 92(3). 35 indexed citations

10.

Nasar, Farooq, Demetrius Matassov, Robert L. Seymour, et al.. (2017). Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. Journal of Virology. 91(8). 16 indexed citations

11.

Matassov, Demetrius, Andrea Marzi, Rong Xu, et al.. (2015). Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. The Journal of Infectious Diseases. 212(suppl 2). S443–S451. 39 indexed citations

12.

Mire, Chad E., Demetrius Matassov, Joan B. Geisbert, et al.. (2015). Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature. 520(7549). 688–691. 67 indexed citations

13.

Datan, Emmanuel, Shawna Benjamin-Davalos, Demetrius Matassov, et al.. (2014). mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection. Virology. 452-453. 175–190. 56 indexed citations

14.

McLean, Jeffrey E., Emmanuel Datan, Demetrius Matassov, & Zahra Zakeri. (2009). Lack of Bax Prevents Influenza A Virus-Induced Apoptosis and Causes Diminished Viral Replication. Journal of Virology. 83(16). 8233–8246. 80 indexed citations

15.

Matassov, Demetrius, Albert Cupo, & Jose M. Galarza. (2007). A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1). Viral Immunology. 20(3). 441–452. 45 indexed citations

16.

Matassov, Demetrius, et al.. (2004). Measurement of Apoptosis by DNA Fragmentation. Humana Press eBooks. 282. 1–18. 135 indexed citations

17.

Garcı́a-Sastre, Adolfo, Andrej Egorov, Demetrius Matassov, et al.. (1998). Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems. Virology. 252(2). 324–330. 825 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact